Anzeige
Mehr »
Dienstag, 09.09.2025 - Börsentäglich über 12.000 News
Tokenisierung entfesselt: Republic führt die Ethereum-Revolution
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CMM6 | ISIN: US64130M2098 | Ticker-Symbol:
NASDAQ
08.09.25 | 20:35
0,865 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEUROONE MEDICAL TECHNOLOGIES CORPORATION Chart 1 Jahr
5-Tage-Chart
NEUROONE MEDICAL TECHNOLOGIES CORPORATION 5-Tage-Chart

Aktuelle News zur NEUROONE MEDICAL TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.08.NeuroOne Medical Technologies Gets Clearance From FDA For OneRF Trigeminal Nerve Ablation System1
18.08.NeuroOne wins FDA nod for nerve ablation system that treats facial pain1
18.08.NeuroOne Medical Technologies Corporation: NeuroOne Receives FDA 510(k) Clearance for OneRF Trigeminal Nerve Ablation System to Treat Facial Pain137FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical...
► Artikel lesen
14.08.NeuroOne raises product gross margin outlook to 53% as management highlights new pain management initiatives1
NEUROONE MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln
14.08.NeuroOne übertrifft im 3. Quartal 2025 die Umsatzerwartungen2
14.08.NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q, Quarterly Report1
14.08.Neuroone Medical: EPS übertrifft Schätzungen um 0,02 $ - Umsatz besser als erwartet3
14.08.NeuroOne Medical Technologies GAAP EPS of -$0.03, revenue of $1.7M1
14.08.NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report1
14.08.NeuroOne Medical Technologies Corporation: NeuroOne Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%113Completed Oversubscribed $8.2 Million Capital Raise; Funded Through At Least Fiscal Year 2026 EDEN PRAIRIE, Minn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq:...
► Artikel lesen
31.07.NeuroOne Medical Technologies Corporation: NeuroOne to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update1
31.07.NeuroOne Medical Technologies Corporation: NeuroOne to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time2
24.07.NeuroOne further boosts its brain electrode IP with new patent1
23.07.NeuroOne receives allowance for key patent from U.S. Patent & Trademark Office2
23.07.NeuroOne receives patent allowance for neural probe technology-
23.07.NeuroOne receives USPTO patent allowance for neural probe technology-
23.07.NeuroOne Medical Technologies Corporation: NeuroOne Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office3
23.06.NeuroOne Medical Technologies Corporation: NeuroOne Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF Ablation System1
03.06.NeuroOne Medical Technologies Corporation: NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary1
13.05.NeuroOne expects FY25 revenue to reach $8M-$10M as OneRF platform advances and new FDA submission broadens pipeline1
Weiter >>
53 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1